<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04986553</url>
  </required_header>
  <id_info>
    <org_study_id>AIRR-0005</org_study_id>
    <nct_id>NCT04986553</nct_id>
  </id_info>
  <brief_title>A Multi-Center, Prospective Registry to Evaluate the Continued Safety and Performance of Clavicle Plates</brief_title>
  <official_title>A Multi-Center, Prospective Registry to Evaluate the Continued Safety and Performance of Clavicle Plates</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arthrex, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Arthrex, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the registry is to evaluate the continued safety and performance of Arthrex&#xD;
      Clavicle Plates used to treat clavicle fractures.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To assess safety, device-related adverse events will be reported and evaluated over the&#xD;
      course of the study. To evaluate the performance imaging of the target area will be evaluated&#xD;
      at three months postoperative. Additionally, patient-reported outcomes will be evaluated at&#xD;
      three months postoperative, 6 months postoperative, and one year postoperative using the&#xD;
      Visual Analogue Scale (VAS), Veterans Rand 12-Item Health Survey (VR-12), and American&#xD;
      Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 20, 2021</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>To assess a change in Visual Analogue Scale (VAS) survey</measure>
    <time_frame>Preoperatively, 3 months, 6 months and 12 months postoperatively</time_frame>
    <description>Patient reported pain scale 0-10 point scale (0 min,10 max)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess a change in Veterans Rand 12-Item Health Survey (VR-12)</measure>
    <time_frame>Preoperatively, 3 months, 6 months and 12 months postoperatively</time_frame>
    <description>Patient reported changes in general health and mental survey. Average score is 50 (negative answers bring scores down, positive answers bring scores up</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess a change in American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES)</measure>
    <time_frame>Preoperatively, 3 months, 6 months and 12 months postoperatively</time_frame>
    <description>ASES is a 100-point scale that consists of two dimensions: pain and activities of daily living. There is one pain scale worth 50 points and ten activities of daily living worth 50 points.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Clavicle Fracture</condition>
  <arm_group>
    <arm_group_label>50 subjects, male and female, at least 18 years of age</arm_group_label>
    <description>50 subjects who are candidates for surgery using the Arthrex Clavicle Plate for treatment of clavicle fractures.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Arthrex Clavicle Plates</intervention_name>
    <description>Arthrex Clavicle Plate for treatment of clavicle fractures</description>
    <arm_group_label>50 subjects, male and female, at least 18 years of age</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Arthrex Clavicle Plates are intended to be used in the general population for clavicle&#xD;
        fractures.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. The subject requires surgery using the Arthrex Clavicle Plate for clavicle fracture.&#xD;
&#xD;
          2. The subject is 18 years of age or over.&#xD;
&#xD;
          3. The subject is not considered a vulnerable subject (i.e., child, pregnant, nursing,&#xD;
             prisoner, or ward of the state).&#xD;
&#xD;
          4. Subject signed informed consent and is willing and able to comply with all study&#xD;
             requirements&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Insufficient quantity or quality of bone.&#xD;
&#xD;
          2. Blood supply limitations and previous infections, which may retard healing.&#xD;
&#xD;
          3. Foreign-body sensitivity.&#xD;
&#xD;
          4. Any active infection or blood supply limitations.&#xD;
&#xD;
          5. Conditions that tend to limit the patient's ability or willingness to restrict&#xD;
             activities or follow directions during the healing period.&#xD;
&#xD;
          6. Subjects that are skeletally immature.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Donna F Williams</last_name>
    <phone>1800-933-7001</phone>
    <email>Donna.williams@arthrex.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sierra Pacific Orthpaedic CenterMedical Group, Inc</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93720</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Julia Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Panorama Orthopedics &amp; Spine Center, PC</name>
      <address>
        <city>Golden</city>
        <state>Colorado</state>
        <zip>80401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Patrick Mc Nair, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 22, 2021</study_first_submitted>
  <study_first_submitted_qc>July 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 3, 2021</study_first_posted>
  <last_update_submitted>July 22, 2021</last_update_submitted>
  <last_update_submitted_qc>July 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

